Health Condition 1: C00-D49- Neoplasms Health Condition 2: A00-B99- Certain infectious and parasitic diseases Health Condition 3: D50-D89- Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism Health Condition 4: E00-E89- Endocrine, nutritional and metabolic diseases Health Condition 5: G00-G99- Diseases of the nervous system Health Condition 6: I00-I99- Diseases of the circulatory system Health Condition 7: J00-J99- Diseases of the respiratory syste
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: People with Advanced and Terminal illnesses are admitted to ICUs. ICU physicians (senior and junior), nurses (across cadres), and palliative care specialists. Hospital administrators, ethicists, and legal experts. Caregiver/family representatives, especially from lower socioeconomic backgrounds. Types of caregivers we anticipate are - Primary family caregiver (spouse, child), Legal surrogate (next of kin), Professional caregiver (in institutions) Public hospital staff, district-level champions, and voices from tribal/rural communities.
Exclusion criteria
Exclusion criteria: - Patients not diagnosed with advanced or terminal illnesses. - Patients who are receiving care outside ICU settings. - Healthcare professionals who are not directly involved in ICU or palliative care (e.g., outpatient clinic physicians, general practitioners). - Administrators, ethicists, or legal experts who do not have direct hospital or ICU-related experience. - Caregivers who are not actively involved in patient care (e.g., distant relatives or informal acquaintances). - Policy makers or researchers not directly involved in ICU or palliative care management.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Co-develop the MCACP intervention. Pilot the MCACP intervention in two ICUs with existing palliative care integration. Expand implementation to four ICUs with existing palliative care access. Extend implementation to four ICUs without existing palliative care access. Modify the intervention at every step in this implementation design framework. Develop a national technical resource hub to facilitate widespread adoption of the MCACP in India.Timepoint: at 18 months, 30 months, 42 months, 60 months | — |
Secondary
| Measure | Time frame |
|---|---|
| NILTimepoint: NIL | — |
Countries
India
Contacts
KASTURBA MEDICAL COLLEGE MANIPAL